Current News

PEI launch RegenKit® A-PRP in Ireland

PEI is delighted to announce the launch of the RegenKit® A-PRP - The safe and effective leukocyte-reduced A PRP for musculoskeletal applications - in Ireland. This amazing produxt has been shown to be higly effective in the treatment of chondropathies and tendinopathies.
 

OSTEOARTHRITIS

In osteoarthritis of the knee, hip and shoulder, A-PRP® resulted in improved functional outcomes and reduced pain in patients with early stage disease and has been shown to be markedly more effective than both hyaluronic acid and PRP prepared using a laboratory method.


CHONDROPATHIES:

A-PRP injection in chondropathy of the knee, hip, ankle and shoulder significantly improved the clinical outcomes over time. In all treated sites, a trend of improvement compared to the pre-treatment period was observed, with p-values still significant compared to baseline at the final available follow-up at 3 years.


TENDINOPATHY:

In tendinopathies, A-PRP® treatment provided significant clinical benefits in up to 90% of patients with continuous improvement over time and low levels of relapse and was found to be particularly effective in insertional tendinopathies. Injection of A-PRP is a promising treatment option for sports injuries. This study showed a significant analgesic effect, even though the patients have received only a single A-PRP injection.


PEI will officially launch the RegenKit A-PFP at the annual IOA Conference 2018 which takes place at the Heritage Spa Hotel, Killenard, Portlaoise, Co Laois on Friday, 15th and Saturday, 16th June 2018. If you would like to know more, please contact your local PEI hospital representative or call PEI at +353 1 419 6900.


July 2018
MTWTFSS
25 26 27 28 29 30 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31 1 2 3 4 5